M&A Deal Summary |
|
---|---|
Date | 2015-07-22 |
Target | Thoratec |
Sector | Medical Products |
Buyer(s) | St. Jude Medical |
Deal Type | Add-on Acquisition |
Deal Value | 3.4B USD |
Advisor(s) | Guggenheim Securities (Financial) Latham & Watkins (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1976 |
Sector | Medical Products |
Employees | 18,000 |
Revenue | 5.5B USD (2016) |
St. Jude Medical, Inc. is a medical device manufacturer dedicated to transforming the treatment of most expensive, epidemic diseases. St. Jude Medical five major areas of focus that include heart failure, atrial fibrillation, neuromodulation, traditional cardiac rhythm management and cardiovascular. St. Jude Medical was formed in 1976 and is based in St. Paul, Minnesota.
DEAL STATS | # |
---|---|
Overall | 18 of 18 |
Sector (Medical Products) | 17 of 17 |
Type (Add-on Acquisition) | 17 of 17 |
State (California) | 7 of 7 |
Country (United States) | 15 of 15 |
Year (2015) | 2 of 2 |
Size (of disclosed) | 1 of 14 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2015-05-04 |
Spinal Modulation
Menlo Park, California, United States Spinal Modulation, Inc. is a developer of the Axium Neurostimulator System. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2016-10-18 |
St. Jude Medical -Vascular Closure Products
Saint Paul, Minnesota, United States St. Jude Medical, Inc. -Vascular Closure Products includes Angio-Seal™ and FemoSeal™ vascular closure products. Angio-Seal™ product lines offer healthcare providers an alternative to manual compression for sealing puncture sites on patients who have undergone a catheterization procedure. |
Sell | - |